PTP1B overexpression is strictly related to insulin resistance, whereas PTP1B inhibition or genetic ablation improve glucose homeostasis, cellular sensitivity to both insulin and leptin, and resistance to diet-induced obesity, without inducing hypoglycaemia or toxic effects [14]. The gene discussed is PTPN1; the disease is obesity due to melanocortin 4 receptor deficiency.